Background Oncolytic viruses show potential as tumor therapeutics however not all individuals seem to reap the benefits of therapy. TaqMan centered qPCR. The genotypes were correlated with patient tumor and success imaging data. Results In individuals treated with oncolytic adenoviruses general survival was considerably shorter if the individual got an FcgRIIIa-VV/ FcgRIIa-HR (VVHR) genotype mixture… Continue reading Background Oncolytic viruses show potential as tumor therapeutics however not all